In malignant melanoma and CRC, RIPK3 can interact with ZBP1 through RHIM, driving the recruitment of caspase-6 and caspase-8 to form the ZBP1–PANoptosome complex, which activates the NLRP3 inflammasome and induces PANoptosis. Here, RIPK3 is linked to melanoma.